Table 4

		Kidney transplanted patients: time after renal transplantation (Days)
		0	15	30	45	60	90	120	180	360
αβ T cells (cells/µL) ^a	Inf. patients	634±496^	1188±593	1317±652	1210±571	1162±469	1200±429	1250±553	1356±439	1333±495
αβ T cells (cells/µL) ^a	Not-Inf. patients	690±384^^	1401±796	1300±596	1313±749	1482±574	1345±728	1337±714	1451±582	1448±705
αβ T cells (%) ^b	Inf. patients	94.2±4.9	92.9±4.6	95.4±2.8	93.8±6.0	93.9±5.5	92.3±6.0	92.7±7.3	92.8±6.9	93.2±4.9
αβ T cells (%) ^b	Not-Inf. patients	91.9±5.0	91.9±5.2	93.5±5.2	92.2±3.9	93.5±4.0	92.1±6.5	90.2±6.6	91.0±6.5	91.8±8.3
γδT cells (cells/µL) ^a	Inf. patients	20.6±15.1	54.3±54.9	39.2±32.3	53.0±68.1	46.0±38.9	67.9±82.3	79.8±119.2	77.1±100.4	73.53±70.0
γδT cells (cells/µL) ^a	Not-Inf. patients	47.4±57.4	60.1±61.2	62.2±53.9	65.4±49.9	71.2±44.5	84.8±109.7	99.2±106.8	102.0±68.0	116.75 ± 171
γδ T cells (%) ^b	Inf. patients	3.5±3.1	4.3±3.6	2.80±1.57	3.95±4.1	4.26±3.4	5.26±5.82	5.37±6.1	5.18±5.8	5.43±4.3
γδ T cells (%) ^b	Not-Inf. patients	5.68±6.0	4.76±4.5	4.87±4.3	4.77±3.1	4.73±3.1	5.43±5.4	6.74±5.1	7.13±5.5	7.55±8.3

Means± SD. ^a absolute cell count/μL of blood; ^b results are expressed as % of CD3+ T cells; ^ p<0.05, ^^ p<0.01 versus all the other observation times

Table 4: Peripheral αβ and γδ T cells in kidney transplanted patients who experienced at least one non-CMV infectious episode (Inf.) or no infections (not-Inf.) in the first year after transplantation.